Trump’s Drug-Pricing Policies Fail to Move the Needle
Lowering drug prices may be a top initiative for the Trump administration, but little progress has been made and some voters lack confidence in the president’s ability to keep his promise.
You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.